Evofem Biosciences, Inc. Common Stock
EVFM
EVFM was delisted on the 10th of August, 2022.
8 hedge funds and large institutions have $585K invested in Evofem Biosciences, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 5 closing their positions.
433% more capital invested
Capital invested by funds: $110K → $585K (+$475K)
27% less funds holding
Funds holding: 11 → 8 (-3)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$336K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.24K |
| 3 |
BlackRock
New York
|
+$226 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$148K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$19.8K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$15K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$14K |
| 5 |
CCG
Ceeto Capital Group
Coral Gables,
Florida
|
-$4.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $521K | +$336K | +2,971 | New |
|
2
Northern Trust
Chicago,
Illinois
| $20K | – | – | – |
|
|
3
BlackRock
New York
| $17K | +$226 | +2 | +2% |
|
|
4
UBS Group
Zurich,
Switzerland
| $15K | -$19.8K | -175 | -68% |
|
|
WAS
5
WESPAC Advisors SoCal
Pasadena,
California
| $5K | – | – | – |
|
|
6
Vanguard Group
Malvern,
Pennsylvania
| $4K | -$148K | -1,314 | -99% |
|
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$1.24K | +11 | New |
|
|
LTFS
8
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
9
Geode Capital Management
Boston,
Massachusetts
| – | -$15K | -382 | Closed |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$14K | -331 | Closed |
|
|
CCG
11
Ceeto Capital Group
Coral Gables,
Florida
| – | -$4.7K | -111 | Closed |
|
EVFM Hedge Fund Activity: Q4 2017 in Review
8 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Evofem Biosciences, Inc. Common Stock (EVFM) for Q4 2017, worth a combined $585K — up 433% from $110K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of EVFM and 2 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Deutsche Bank, opening a new position worth an estimated $336K. The largest seller was Vanguard Group, cutting an estimated $148K.
- 8 institutional investors held Evofem Biosciences, Inc. Common Stock (EVFM) as of Q4 2017, down from 11 in Q3 2017.
- Funds reported $585K of Evofem Biosciences, Inc. Common Stock stock for Q4 2017, up 433% quarter-over-quarter.
- 2 funds opened new Evofem Biosciences, Inc. Common Stock positions in Q4 2017 and 5 closed out, a net change of -3 holders.
- The largest Evofem Biosciences, Inc. Common Stock buyer in Q4 2017 was Deutsche Bank, an estimated $336K added.
- The largest Evofem Biosciences, Inc. Common Stock seller in Q4 2017 was Vanguard Group, an estimated $148K sold.
Based on aggregated 13F filings for Q4 2017.